SK Telecom Unveils ‘Aster(A*),’ Its New Global AI Personal Agent at SK AI Summit 2024
– On the second day of the SK AI Summit 2024, SK Telecom introduced Aster(A*), an AI-driven personal assistant designed for global users – Aster is designed... Read more.
HTX Ventures: Crypto’s Impact on 2024 U.S. Election Dynamics
SINGAPORE, Nov. 4, 2024 /PRNewswire/ — HTX Ventures, the global investment division of HTX, today unveils its latest research on crypto and its impact on... Read more.
Hugel’s skincare brand WELLAGE joins K-beauty festival in New York
– The brand introduced its signature Real Hyaluronic Blue 100 Ampoule and new lineup Hyper Peptide Botuleedle Ampoule – It delivered a presentation on... Read more.
Nuvve to Provide Third Quarter 2024 Financial Update
Investor Conference Call to be Held Tuesday, November 12, 2024 at 5:00 PM Eastern Time (2:00 PM PT) SAN DIEGO, Nov. 4, 2024 /PRNewswire/ — Nuvve Holding Corp.... Read more.
ScriptsMD Makes Semaglutide Weight Loss Treatment Accessible and Affordable
DELRAY BEACH, Fla., Nov. 4, 2024 /PRNewswire/ — ScriptsMD is an innovative healthcare solution that provides Americans with affordable access to semaglutide... Read more.
GTN and SBI Group collaborate to launch “SBI Saudi Arabia Equity Exchange Traded Fund (ETF)”
The launch marks the first ETF dedicated to investing in the Saudi Arabian stock market listed on the Tokyo Stock Exchange. DUBAI, UAE, Nov. 4, 2024 /PRNewswire/... Read more.
Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight
Exosomes are emerging as key tools in personalized and regenerative medicine, offering precise, targeted therapy with low immune risk. Their potential spans cancer,... Read more.
Xiao-I Corporation Provides Update on Shanghai Xiao-I’s Patent Infringement Lawsuit Against Apple
SHANGHAI, Nov. 4, 2024 /PRNewswire/ — Xiao-I Corporation (NASDAQ: AIXI), a leading developer of AI solutions, today provided an update on its VIE’s ongoing... Read more.
Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight
Exosomes are emerging as key tools in personalized and regenerative medicine, offering precise, targeted therapy with low immune risk. Their potential spans cancer,... Read more.
Xiao-I Corporation Provides Update on Shanghai Xiao-I’s Patent Infringement Lawsuit Against Apple
SHANGHAI, Nov. 4, 2024 /PRNewswire/ — Xiao-I Corporation (NASDAQ: AIXI), a leading developer of AI solutions, today provided an update on its VIE’s ongoing... Read more.